A simple, secure interface for the care team
Resilience's remote monitoring platform, a class IIa medical device, enables healthcare professionals to improve remote monitoring of their patients by giving them the possibility of :
- Measure treatment-related symptoms with tailored e-PRO questionnaires
- Follow their evolution and be notified in real time according to the severity of reported side effects
- Quickly identify at-risk patients and adapt treatments to their needs
Dr Antoine Lemaire
Head of Oncology and Medical Specialties, Centre Hospitalier de Valenciennes
"The idea is that we can have a vision of the patient's progression of care, even outside of hospital walls, and anticipate problems as they come."
Dr Joana Ribiero
Medical oncologist, Gustave Roussy
"Remote monitoringhas greatly improved the quality of care here (...) It's a win for patients and a win for us."
Dr Thomas Grellety
Oncologist and Head of Department, Centre Hospitalier de la Côte Basque
"It provides us with continuous feedback and a way to focus our actions, including for those of our Advanced Practice Nurse, for specific patients in demand."
Dr Laura Polastro
Medical oncologist in gynecology and senology, Institut Jules Bordet
"Resilience is an easy tool to understand and is greatly endorsed by patients. It is therefore a very interesting to monitor my patients."
Dr Barbara Pistilli
Head of the Breast Pathology Committee, Gustave Roussy
"It's a great resource for our patients because they have a very personalized follow-up tailored to their needs. It's also a great resource for us professionals as we don't have such a gap between two consultations, or between two chemotherapy sessions."
Prof. Ethan Basch
Oncologist and Director of Research, University of North Carolina
"It's our job to take care of our patients, whether they're in clinic or at home. The only way to take care of them is to understand what they go through on a daily basis, and we need tools to help us do that."
Ms Nathanaëlle Leprevier
Nurse coordinator, Centre Hospitalier de Valenciennes
"Resilience allows us to anticipate the scheduling of supportive care when patients come to the day hospital. Now everyone has access to a regular follow-up. There's no going back."
Dr Thomas Grellety
Oncologist and Head of Department, Centre Hospitalier de la Côte Basque
"You'll now be able to devote medical and paramedical time simply for needs that emerges and when they emerge."
Prof. Etienne Minvielle
Doctor of Public Health at Gustave Roussy and Director of Research at CNRS
"[With remote monitoring], we can prevent major toxic effects. We improve the patient experience, [they] appreciate this close follow-up. And lastly [...], in economic terms, we reduce the number of days of hospitalization. It's very encouraging, because we're on the triptych of quality of care, patient experience and cost reduction. As far as we know, this is one of the first demonstrations for all cancers."
Dr Antoine Lemaire
Head of Oncology and Medical Specialties, Centre Hospitalier de Valenciennes
"I see remote monitoring as a tool that will enable us to be more efficient and to have a vision of a continuum of care for patients."
Facilitating care coordination and maintaining links with patients
99% of the time, a patient is not under the supervision of his or her oncologist. The link between patients and their care teams can weaken. Strengthening it has become a necessity to avoid, for example, non-compliance with treatment. Resilience enables patients to benefit from local support, even at a distance.
92%
Of healthcare professionals find that Resilience integrates appropriately into their organization.*
72%
Of nurses report that Resilience improves communication with their patients.*
62%
Of doctors report that Resilience can detect early deterioration or the onset of undesirable events.
Sources
*Satisfaction survey conducted by Resilience among healthcare professionals using the solution - December 2022
e-PRO questionnaires tailored to your patients' needs
Created by oncologists and researchers, the construction of our adapted e-PRO (electronic Patient-Reported Outcome) questionnaires strictly follows ESMO guidelines. Applicable to all types of cancer, they are comprised of generic and specific questions that capture the impact of different tumor types and/or treatments, with a level of evidence and a grade of recommendation [I,A].
.webp)
.webp)
.webp)
1. Patient assesses symptoms
They receive e-PRO questionnaires regularly
They can report and measure their on a daily basis
They can access digital supportive care content and programs developed by experts and healthcare professionals
Real-time data collection
2. Nurses handle alerts
Symptom grading and intelligent alert system
Identifying problems and prioritizing of the active file
Proactive patient contact and referral
Setting up an appropriate care plan
3. The oncologist intervenes if necessary
Adapting of treatment
New or renewed prescription
Consultation or hospitalization
Scientifically proven clinical and organizational benefits
Remote medical monitoring in oncology has proven its impact on patient health and care organization through several French and international clinical trials.
Clinical benefits for patient's health
4%
Relative Dose Intensity (1)
-9,3%
Treatment-related toxicities (grade ≥3) (1)
+5,2%
Of months of overall survival (2)
Benefits for patient care
-1,62
Day of hospitalization (1)
-6,9
Emergency room use (1)
Sources
(1) Mir, O., Ferrua, M., Fourcade, A. et al. Digital remote monitoring plus usual care versus usual care in patients treated with oral anti-cancer agents: the randomized phase 3 CAPRI trial. Nat Med (2022). doi.org/10.1038/s41591-022-01788-1.
(2) Basch, Ethan et al. "Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A RandomizedControlled Trial." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34.6 (2016): 557-65. doi:10.1200/JCO.2015.63.0830
Safety and regulatory compliance as mainstays
Our software has been designed in accordance with the most stringent international standards in terms of quality management, information security management system security (ISO 27001:2022 certification) and medical device design. We also place a great emphasis on protecting our users' personal data and complying with European regulations.
Class IIa medical device
- Medical device CE-marked (class IIa) under MDD 93/42
- Certified by GMED and registered with ANSM
- Compliant with European MDR 2017/745 (article 120)
- France's only Class IIa-certified platform
Secure data collection
- Solutions developed with the protection of our users' data (healthcare professionals and patients) in mind
- Increased support from CNIL throughout 2021
- RGPD compliance
- Healthcare data stored in France by approved healthcare data hosts (Ecritel, OVHcloud)
Meet our teams at upcoming events
The Resilience team is at your service
Amina, Eugénie and Timothée, our Partnership Managers, will be happy to tell you more about Resilience and telemonitoring in oncology, and the impact of telemonitoring in oncology.
.webp)
Contact us
Are you a healthcare professional interested in finding out more about Resilience? We'd love to hear from you!
Understanding and monitoring to optimize medical intervention
Thanks to real-time data collection and an intelligent alert system, the care team can detect and predict relapses, toxicities or complications experienced by patients. Resilience also enables healthcare teams to proactively adapt management and improve treatment coordination.